Global approval status of Imdelltra by end of 2024 | Categorical | | | 7 months ago | |
Will Imdelltra become a blockbuster seller by May 2024? | Binary | | | 7 months ago | |
Will severe CRS & Icans side effects from Imdelltra be reported by end of 2024? | Binary | | | 7 months ago | |
Will Imdelltra receive FDA approval for other cancer types by May 2025? | Binary | | | 7 months ago | |
Market performance of Imdelltra compared to other new cancer drugs by end of 2024 | Categorical | | | 7 months ago | |
Imdelltra reduces mortality rate for ES-SCLC by May 2024 | Binary | | | 7 months ago | |
Financial impact from Imdelltra sales in 2024 | Categorical | | | 7 months ago | |
Global adoption of Imdelltra as standard treatment by end of 2024 | Categorical | | | 7 months ago | |
Imdelltra approved for other cancer types by end of 2024 | Binary | | | 7 months ago | |
Severe side effects lead to Imdelltra discontinuation by end of 2024 | Binary | | | 7 months ago | |
Global regulatory approvals for Imdelltra by 2024 end | Categorical | | | 7 months ago | |
Imdelltra sales exceed $500 million by end of 2024? | Binary | | | 7 months ago | |
New SCLC competitor drug approved by FDA in 2024? | Binary | | | 7 months ago | |
Amgen to initiate further Imdelltra trials for other cancers by 2024 end? | Binary | | | 7 months ago | |
Imdelltra's market share in SCLC treatments by 2024 end | Categorical | | | 7 months ago | |
FDA's regulatory actions on Imdelltra post-2024 surveillance | Categorical | | | 7 months ago | |
Global Approval Reach of Imdelltra by End of 2024 | Categorical | | | 7 months ago | |
Competing Drug for Imdelltra by Mid-2025? | Binary | | | 7 months ago | |
Imdelltra Sales Reach $500M by Year End? | Binary | | | 7 months ago | |
Full FDA Approval for Imdelltra by May 2025? | Binary | | | 7 months ago | |
Impact of Imdelltra on Amgen's total revenue by end of 2024 | Categorical | | | 7 months ago | |
Amgen stock performance following Imdelltra success by end of 2024 | Categorical | | | 7 months ago | |
Market Share of Imdelltra by End of 2024 | Categorical | | | 7 months ago | |
Impact of Imdelltra on Patient Survival Rates by End of 2025 | Categorical | | | 7 months ago | |
